杨娜, 张化冰, 李玉秀. 《美国糖尿病学会2019年版糖尿病医学诊疗标准》更新与解读[J]. 协和医学杂志, 2019, 10(5): 476-480. DOI: 10.3969/j.issn.1674-9081.2019.05.009
引用本文: 杨娜, 张化冰, 李玉秀. 《美国糖尿病学会2019年版糖尿病医学诊疗标准》更新与解读[J]. 协和医学杂志, 2019, 10(5): 476-480. DOI: 10.3969/j.issn.1674-9081.2019.05.009
Na YANG, Hua-bing ZHANG, Yu-xiu LI. Interpretation on the Update of American Diabetes Association Standards of Medical Care in Diabetes—2019[J]. Medical Journal of Peking Union Medical College Hospital, 2019, 10(5): 476-480. DOI: 10.3969/j.issn.1674-9081.2019.05.009
Citation: Na YANG, Hua-bing ZHANG, Yu-xiu LI. Interpretation on the Update of American Diabetes Association Standards of Medical Care in Diabetes—2019[J]. Medical Journal of Peking Union Medical College Hospital, 2019, 10(5): 476-480. DOI: 10.3969/j.issn.1674-9081.2019.05.009

《美国糖尿病学会2019年版糖尿病医学诊疗标准》更新与解读

Interpretation on the Update of American Diabetes Association Standards of Medical Care in Diabetes—2019

  • 摘要: 糖尿病是目前最常见的慢性非传染性疾病之一, 美国糖尿病学会(American Diabetes Association, ADA)每年都会发布一版糖尿病医学诊疗标准, 2019年版已于2018年12月发布, 该诊疗标准为广大临床工作者在糖尿病的预防、诊断、治疗等方面提供了指导意见。本文主要对该版指南中更新的部分内容, 包括糖尿病用药方面尤其是合并动脉粥样硬化性心血管疾病、慢性肾脏病及心力衰竭的糖尿病患者的二联用药选择, 注射性降糖药物的选择, 糖尿病血压控制目标及阿司匹林使用等方面的内容进行解读, 以供临床医师参考。

     

    Abstract: Diabetes mellitus is one of the most common chronic non-infectious diseases. The American Diabetes Association publishes a new version of Diabetes Medical Standards every year that provides guidance for clinicians in the prevention, diagnosis, and treatment of diabetes. The latest version was released in December 2018. This article interprets some of the updated contents in this edition of the Standards for reference, including Diabetic medications especially for patients with arteriosclerosis cardiovascular disease, chronic kidney disease, or heart failure, choices of injectable hypoglycemic agents, goals of blood pressure control, and the use of aspirin.

     

/

返回文章
返回